1393685-92-1

Basic information

• Product Name: 4-[4-(4-amino-2,5-difluorophenyl)cyclohexylideneaminooxy]piperidin-1-carboxylic acid isopropyl ester
• Synonyms: 4-[4-(4-amino-2,5-difluorophenyl)cyclohexylideneaminooxy]piperidin-1-carboxylic acid isopropyl ester
• CAS NO: 1393685-92-1
• Molecular Weight: 409.476
• Mol File: 1393685-92-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-[4-(4-amino-2,5-difluorophenyl)cyclohexylideneaminooxy]piperidin-1-carboxylic acid isopropyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[4-(4-amino-2,5-difluorophenyl)cyclohexylideneaminooxy]piperidin-1-carboxylic acid isopropyl ester(1393685-92-1)
• EPA Substance Registry System: 4-[4-(4-amino-2,5-difluorophenyl)cyclohexylideneaminooxy]piperidin-1-carboxylic acid isopropyl ester(1393685-92-1)

Safety Data

• Hazardous Substances Data: 1393685-92-1(Hazardous Substances Data)

Upstream product

• 1393685-67-0 4-(4-amino-2,5-difluorophenyl)cyclohexanone 
• 1393685-66-9 4-(1,4-dioxa-spiro[4.5]dec-8-yl)-2,5-difluorophenylamine 
• 1393685-65-8 8-(2,5-difluoro-4-nitrophenyl)-1,4-dioxa-spiro[4.5]dec-7-ene 
• 143539-99-5 tert-butyl 4-(1,3-dioxo-1,3-dihydroisoindol-2-yloxy)piperidine-1-carboxylate 
• 867034-25-1 tert-butyl 4-(aminooxy)piperidine-1-carboxylate 
• 680596-79-6 4,4,5,5-tetramethyl-2-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)-1,3,2-dioxaborolane 
• 109384-19-2 t-butyl 4-hydroxy piperidine-1-carboxylate 
• 167415-27-2 1-bromo-2,5-difluoro-4-nitrobenzene 
• 1393685-68-1 4-[4-(4-amino-2,5-difluorophenyl)cyclohexylideneaminooxy]piperidin-1-carboxylic acid tert-butyl ester 
• 108-23-6 isopropyl chloroformate 

Relevant articles and documents

OXIME DERIVATIVES AS GPR119 AGONISTS

The present invention relates to oxime derivatives, a method for preparing the same, a pharmaceutical composition comprising the same and use thereof. The oxime derivatives according to the present invention act as GPR119 agonists to stimulate the secretion of insulin and promote GLP-1 formation for preventing or treating type 2 diabetes, complications of diabetes, obesity, dyslipidemia or osteoporosis.